Justin D. Gover, Chief Executive Officer at GW PHARMACEUTICALS PLC (GWPH), sold 57,312 shares at $8.40 ($477K) on 2020-03-02, disclosed to the SEC on 2020-03-04.
Open-market sale of $477k GWPH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.31 | 24,456 | $203K | 42.6% |
| 2 | $8.31 | 24,456 | $203K | 42.6% |
| 3 | $8.40 | 8,400 | $71K | 14.8% |
| Total | $8.32 avg | 57,312 | $477K | 100% |
| Filing → |
| GWPH | SELL | 2020-02-28 | $194K | — | Filing → |
| GWPH | SELL | 2020-02-05 | $3.9M | — | Filing → |
| GWPH | SELL | 2019-12-19 | $49K | — | Filing → |